Why This Article Exists
Peptide You by BritePear exists as a personal transparency and education platform. The compounds we cover are studied in the context of health, recovery, metabolic function, and longevity, outside of competitive sport. But Peptide You by BritePear has readers who compete. Some are recreational athletes. Some are tested. Some are elite.
The information in these articles could, if misapplied, result in the end of a competitive career. That matters more than staying on-brand. This article is a plain-language guide to what WADA prohibits, what it detects, what it sanctions, and which Peptide You by BritePear compounds belong in each category, so no reader walks into a violation they could have avoided.
"The most dangerous moment in doping control isn't when an athlete knowingly cheats. It's when a well-intentioned athlete, given a healing compound by a physician or a supplement from a trusted store, doesn't know it's on the prohibited list, and competes anyway. WADA's strict liability standard treats both cases identically."
Understanding WADA: The Framework
What WADA Is
The World Anti-Doping Agency is an independent international body established in 1999 that produces the World Anti-Doping Code, the unified framework for anti-doping rules across Olympic sports, Paralympic sports, and most professional and collegiate programs. The WADA Prohibited List is updated annually, takes effect January 1st each year, and is the definitive authority for what is and is not allowed.[1]
National anti-doping agencies, USADA in the US, UKAD in the UK, ASADA in Australia, and dozens of others, are signatories that enforce the WADA Code. Professional leagues (NFL, MLB, UFC, Premier League) maintain their own programs but typically model them on the WADA List, sometimes with additional restrictions or different procedures.
The Three-Part Test for Prohibition
WADA prohibits a substance if it meets two of three criteria: it enhances or has the potential to enhance sport performance; it represents an actual or potential health risk; or it violates the spirit of sport. For most peptides covered in Peptide You by BritePear, all three criteria apply, even if the athlete's intent was purely therapeutic.[2]
WADA Categories Relevant to Peptide You by BritePear
S0, Non-Approved Substances is the broadest and most severe category. It covers any pharmacological substance not approved for human therapeutic use by any governmental regulatory health authority in the world. Every compound in S0 is a non-Specified Substance, meaning violations carry the full default sanction without reduction for contamination arguments. BPC-157 sits here.
S2, Peptide Hormones, Growth Factors, Related Substances & Mimetics covers a wide range of compounds that interact with growth hormone pathways, tissue growth, and anabolic signaling. CJC-1295, Ipamorelin, AOD-9604, and TB-500 all live here. S2 substances are prohibited at all times, in and out of competition.
Strict Liability: The Rule That Changes Everything
WADA operates on the principle of strict liability, meaning an athlete is responsible for any prohibited substance found in their body, regardless of how it got there, whether they knew about it, or whether they intended to cheat.[3] The only variable is sanction length, which can be reduced if an athlete demonstrates no significant fault. But the violation itself stands.
This means "my doctor prescribed it," "I didn't know it was banned," "I bought it legally online," and "I only used it in the off-season" are not defenses to a violation. They may reduce the sanction, but they don't eliminate it.
No TUE Pathway for Most Peptides
A Therapeutic Use Exemption (TUE) allows athletes to use a prohibited substance for a legitimate medical condition under physician supervision. However, TUEs are only available for substances with approved medical indications. BPC-157, TB-500, CJC-1295, Ipamorelin, and AOD-9604 have no FDA-approved indications, which means there is no TUE pathway for any of them.[4] An athlete cannot receive a medical exemption for a compound that hasn't passed clinical trials.
Non-Analytical Positives: You Don't Need to Fail a Test
One of the least understood aspects of anti-doping enforcement is that an athlete can be sanctioned without ever producing a positive sample. Anti-doping rule violations can be established through admissions, witness testimony, purchase records, text messages, and intelligence-gathering, what's known as a non-analytical positive.[5] Documented cases of BPC-157 violations have been pursued this way. If you posted about using a banned substance on social media, told a training partner, or bought from a traceable source, the record exists without a test ever occurring.
The Complete Peptide You by BritePear Anti-Doping Reference
Below is every compound covered in the Peptide You by BritePear curriculum mapped to its current WADA status, relevant category, and what is known about detection windows. Always verify with USADA's Drug Reference Online or your sport's governing body before competition, as the Prohibited List is updated annually.
TUE Available: No, no approved medical indication exists.
Half-Life: Under 30 minutes (plasma clearance within 4–6 hours).
Urine Detection Window: Minimum 72 hours; up to 4 days via LC-MS/MS metabolite detection. Stable metabolite confirmed at 0.1 ng/mL sensitivity.[6]
Blood Detection: Parent compound clears within 4–6 hours; metabolite detection extends this window.
Testing Method Required: Specialized LC-MS/MS, NOT detected by standard immunoassay panels.
Real-World Sanction: 19-year-old US speed skater, 1-year ban (2024). Combined BPC-157 + TB-500 case (Emma Brooks, volleyball), 4-year ban.[7]
Other Organizations: NFL, UFC, MLB, DoD/Military, NCAA (under peptide hormone bans), all prohibited.
TUE Available: No, no approved medical indication exists.
Half-Life: Approximately 2–3 hours.
Urine Detection Window: Parent compound 24–72 hours; metabolites (particularly Ac-LKKTE) extend the window further. WADA has funded specific human detection research for this compound.[9]
Blood Detection: Equine studies confirmed detection at 0.02 ng/mL in plasma. Human detection methods are actively being refined and improved.
Testing Method Required: LC-MS, ion-exchange solid phase extraction. Not detectable by standard panels.
Note: Because TB4 is naturally occurring, detection methods must distinguish the synthetic acetylated fragment from endogenous levels, an active area of anti-doping research.
TUE Available: No, not FDA-approved for general use.
Half-Life: CJC-1295 with DAC: 6–8 days. Without DAC (Mod-GRF 1-29): 30 minutes.
Detection Window: Parent compound detectable in urine and blood. The long-acting DAC version has an extended window commensurate with its half-life. GHRH analogs are routinely included in anti-doping screening panels at accredited labs.[10] Conservative estimate for DAC form: 2–4 weeks.
Notes: Even though CJC-1295 works indirectly (stimulating your own GH rather than adding exogenous HGH), it is fully prohibited. The mechanism of action doesn't create an exemption.
TUE Available: No.
Half-Life: Approximately 2 hours.
Detection Window: GHRPs including ipamorelin are detectable in urine for approximately 24–36 hours post-administration using LC-MS/MS. Validated multi-peptide screening methods include ipamorelin in routine anti-doping panels.[10]
Notes: Often stacked with CJC-1295. Both compounds are prohibited individually; stacking compounds the violation, not the sanction. However, detection of either means a positive.
TUE Available: No, failed to achieve drug approval despite Phase III clinical trials. No approved indication.
Half-Life: Approximately 30 minutes.
Detection Window: As a fragment of HGH, detection methods for HGH peptide fragments apply. Estimated 24–48 hours for parent compound; metabolite-based detection extends this window.
Notes: AOD-9604's FDA GRAS designation (for food use) creates a dangerous false sense of legality for athletes. GRAS as a food ingredient does not override its explicit prohibition as a performance-enhancing substance under WADA's S2 category.
Practical Risk: HIGH. If tested, an anti-doping authority could argue Semax falls under the S0 catch-all. No ruling has been published definitively, but the legal framework supports prohibition.
TUE Available: No pathway, no recognized approved indication.
Athlete Recommendation: Treat as prohibited. Do not use if subject to any form of drug testing.
Practical Risk: HIGH. Same legal exposure as Semax under S0's unapproved substance provision.
Athlete Recommendation: Treat as prohibited. Do not use if subject to testing.
Practical Risk: MODERATE-HIGH. Less likely to appear in routine testing panels due to obscurity, but the legal exposure under S0 is identical to Semax and Selank if tested.
Athlete Recommendation: Treat as prohibited. The longevity framing of Epithalon does not create an athletic exemption.
Monitoring Program: Not currently on WADA's monitoring list for potential addition.
Practical Notes: Always verify supplement purity, products tested by NSF Certified for Sport, Informed Sport, or BSCG reduce contamination risk from undeclared banned substances. While NMN/NR themselves are not banned, a contaminated product could still produce a positive result for a different prohibited compound.
Status Stability: Unlikely to be added in the near term given dietary supplement status, but the WADA List updates annually. Confirm before each competition season.
Important Context: WADA has been monitoring GLP-1 receptor agonists, and their status should be verified annually as this class gains wider use and research attention. Some sports governing bodies may have their own positions, verify with your specific sport's authority.
Note: Retatrutide (triple GIP/GLP-1/glucagon agonist) is investigational. Its regulatory status and WADA monitoring status should be confirmed before competition use.
Practical Notes: Cosmetic and topical applications of peptides like GHK-Cu are very unlikely to produce detectable systemic levels. Injectable or systemic use of any unlisted compound raises S0 risk. Verify any peptide not on the list against the S0 catch-all provision.
Detection Technology: Why Standard Tests Don't Catch These
Most people assume that if something is banned, a standard drug test will catch it. For peptides, that assumption is wrong, and understanding why matters for both athletes and anti-doping administrators.
Standard workplace and basic athletic drug tests use immunoassay technology, antibodies engineered to recognize specific molecular shapes, primarily small organic molecules like steroids, amphetamines, opioids, and cannabinoids. Peptides are structurally nothing like these compounds. Their molecular complexity, size, and charge characteristics make standard immunoassay panels completely blind to them. You could inject BPC-157 the morning of a basic drug test and produce a clean panel.
WADA-accredited laboratory testing is entirely different. These labs use liquid chromatography-high resolution mass spectrometry (LC-HRMS), instruments that can identify compounds by exact molecular weight and fragmentation pattern at concentrations below 0.1 ng/mL in urine. This technology can find a peptide or its metabolite even days after the parent compound has cleared the bloodstream. The equipment costs hundreds of thousands of dollars, requires highly specialized operators, and is specifically designed to detect the compounds on the WADA Prohibited List.[12]
Estimated Detection Window Reference
| Compound | Plasma Half-Life | Urine Detection Window | Testing Method | Confidence |
|---|---|---|---|---|
| BPC-157 | <30 min | 72 hrs – 4 days (metabolite) | LC-MS/MS (weak cation exchange SPE) | Validated in published research[6] |
| TB-500 | 2–3 hrs | 24–72 hrs (active metabolite extends) | LC-MS (ion-exchange SPE) | WADA-funded equine studies; human refinement ongoing[9] |
| CJC-1295 (DAC) | 6–8 days | Est. 2–4 weeks | LC-HRMS peptide screening | Long half-life implies extended window; exact human data limited |
| Ipamorelin | ~2 hrs | 24–36 hrs | LC-MS/MS multi-GHRP panel | Validated in anti-doping research[10] |
| AOD-9604 | ~30 min | 24–48 hrs (estimated) | LC-HRMS (GH fragment methods) | Extrapolated from HGH fragment detection methodology |
| Semax / Selank | Short (minutes–hours) | Unknown, no validated method published | Research-grade LC-MS | S0 exposure regardless of current detection capability |
| Epithalon | Short (tetrapeptide) | Unknown, no validated method published | Not established in anti-doping literature | S0 exposure regardless of current detection capability |
| NMN / NR | N/A, not prohibited | Not tested | Not applicable | Not prohibited as of 2025 |
Detection windows are estimates based on published research and pharmacokinetic data. Individual variation in metabolism, dose, frequency of use, and route of administration all affect actual detection times. Always assume the conservative (longest) estimate when making decisions about competition timing.
Documented Sanctions: Real Cases
These are not hypothetical. The following cases demonstrate that enforcement of peptide prohibitions is active, consequential, and targeted at athletes at every level.
| Athlete / Case | Sport | Substance(s) | Sanction | Notes |
|---|---|---|---|---|
| US Speed Skater (19 years old) | Speed Skating | BPC-157 | 1-year ban (2024) | Highlighted early-career risk; athlete reportedly unaware of ban status[7] |
| Emma Brooks | Volleyball | BPC-157 + TB-500 | 4-year ban | Canadian Centre for Ethics in Sport; non-Specified Substance classification drives longer default sanction[7] |
| Combat Sport Athlete (unnamed) | Combat Sports | BPC-157 | 2-year suspension (2023) | Substance marketed as "legal" by supplier; supplier's claim offers no protection[13] |
The Non-Specified vs. Specified Substance Distinction
This is a detail that directly affects sanction length and it's worth understanding. Under WADA rules, substances fall into two categories: Specified Substances (where contamination arguments carry more weight and sanctions may be reduced) and non-Specified Substances (where the full default sanction applies with fewer options for reduction).
BPC-157, as an S0 compound, is a non-Specified Substance. The default sanction for a first violation is a four-year ban. TB-500 under S2 is a Specified Substance, the default is four years, but a reduced sanction (as low as two years or even less) may apply if the athlete can demonstrate how the substance entered their system and that there was no significant fault.[3]
The practical implication: an athlete who tests positive for BPC-157 is in a significantly worse position than one who tests positive for TB-500, even though both are prohibited. Knowing this distinction before choosing compounds is material information.
Which Sports Organizations Follow WADA
The scope of WADA's reach is broader than most athletes realize. The following organizations adopt the WADA Prohibited List or maintain equivalent or stricter standards:
All Olympic and Paralympic sports, all organizations under the World Anti-Doping Code signatories (over 700 sports organizations globally), the United States Anti-Doping Agency (USADA), UK Anti-Doping (UKAD), the NCAA (National Collegiate Athletic Association), the NFL (uses its own list but peptide hormones are prohibited), Major League Baseball, the UFC (through USADA), Voluntary Anti-Doping Association (VADA, used in boxing), CrossFit Games (through Drug Free Sport International), most professional cycling (through UCI), and the US Department of Defense for all military personnel under DoDI 6130.06.[14]
Recreational athletes competing in local, regional, or non-tested competitions are typically outside the jurisdiction of these organizations. But any competition that markets itself as "tested" or "natural", bodybuilding federations, masters athletics, powerlifting organizations, maintains its own testing programs that may include peptide screening.
The Ask I Make of Every Competitive Athlete Who Reads Peptide You
BritePear exists because I believe people deserve to understand the tools available to them, clearly, honestly, and without agenda. That same standard applies here. If you compete in a tested sport and you're reading these articles looking for a recovery edge, I want you to have the complete picture.
The healing biology of BPC-157 is real. The GH-axis science behind CJC-1295 and Ipamorelin is well-supported. I don't think less of anyone who has used these compounds, and I don't believe every person who has ever taken a banned substance is a cheater by intent. But intent doesn't determine outcomes under WADA rules, and I can't in good conscience share the upside without making the downside equally clear.
If you compete: check every compound with USADA's Drug Reference Online (usada.org) or your national anti-doping authority's equivalent before you use anything. If you're working with a physician on any of these protocols, make sure they understand you are a tested athlete before a single vial is prescribed. The cost of not doing this is measured in years of your career.
"The spirit of sport isn't just a phrase. It's the philosophical framework that governs why anti-doping exists at all. Even if you believe a compound is therapeutic rather than performance-enhancing, using it in competition without disclosure violates the transparency that makes sport meaningful. That's a position worth holding."
Resources for Tested Athletes
USADA Drug Reference Online: usada.org/substances/drug-reference, search any substance for its WADA status. Free, updated regularly.
Global DRO (globaldro.com): Searchable database covering the US, UK, Canada, and Australia.
WADA Prohibited List (current year): wada-ama.org/en/prohibited-list
Certified Supplement Programs: NSF Certified for Sport, Informed Sport, and BSCG are third-party testing programs that screen supplements for banned substance contamination, relevant for NMN, NR, and other permitted compounds where product purity is the risk.